RCS - Tekcapital plc - Strategic Alliance signed with Nexscient Inc

TekcapitalAnnouncement

Mon 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251110:nRSJ7696Ga&default-theme=true

RNS Number : 7696G  Tekcapital plc  10 November 2025

 

 

 
            10 November 2025

Tekcapital plc

("Tekcapital", the "Company" or the "Group")

  Nexscient and Tekcapital sign a Strategic Alliance

    to Accelerate GenAI-Driven Technology Acquisitions

 

Tekcapital plc (AIM: TEK), the UK intellectual property investment group
focused on transforming university technologies into valuable products that
can improve people's lives, is pleased to announce it has entered into a
strategic alliance with Nexscient, Inc. (OTCQB: NXNT), an innovator in
artificial intelligence ("AI") applications and intelligent enterprise
solutions, to identify and help acquire transformative intellectual property
assets for Nexscient from research institutions worldwide.

 

Under the alliance, Tekcapital will leverage its extensive university and
technology network to identify and facilitate Technology Acquisition
Opportunities that align with Nexscient's AI and advanced computing focus
areas.  Nexscient will evaluate and pursue acquisitions or licenses of these
innovations through strategic transactions aimed at creating long-term
shareholder value.

 

Fred E. Tannous, Chief Executive Officer of Nexscient, Inc. said:

"This alliance with Tekcapital represents a powerful extension of Nexscient's
vision to identify, fund, and commercialize high-impact AI technologies.
Tekcapital's unparalleled access to global university innovation, combined
with our ability to integrate and scale those technologies into commercial AI
solutions, creates a dynamic pathway from academic discovery to market
transformation.  We believe that this collaboration accelerates our mission
to deliver the next dimension of AI."

 

Under the terms of the agreement, Tekcapital will provide Nexscient with
continuous access to a curated pipeline of university-originated technologies
that meet Nexscient's acquisition profile.  Tekcapital will identify
technology acquisition candidates, lead early-stage negotiations, and where
appropriate, structure initial transactions for technologies that Nexscient
may acquire using Nexscient stock as consideration.

 

Dr. Clifford M. Gross, Executive Chairman of Tekcapital, commented:

"We're delighted to enter this alliance with Nexscient and its visionary
leadership team. By linking Tekcapital's global innovation sourcing
capabilities with Nexscient's executional strength, we are enabling a
fast-track mechanism for converting GenAI research breakthroughs into
value-generating enterprises.  We believe this is precisely the kind of
collaboration that helps to bridge the gap between invention and
implementation."

 

Both organizations have agreed to update the market when significant
milestones are achieved under this alliance.

 

For further information, please contact:

 Tekcapital plc                                                                 Via Flagstaff
 Clifford M. Gross, Ph.D.

 SP Angel Corporate Finance LLP                                                 +44 (0) 20 3470 0470

 (Nominated Adviser and Broker)
 Richard Morrison/Charlie Bouverat (Corporate Finance)

 Abigail Wayne / Rob Rees (Corporate Broking)

 Flagstaff Strategic and Investor Communications                                +44 (0) 20 7129 1474
 Tim Thompson/Andrea Seymour/Fergus Mellon

 

About Nexscient, Inc.

Nexscient® [OTCQB: NXNT] is an emerging-growth AI company that leverages its
technical expertise, business acumen, and capital resources to identify, fund,
integrate, and commercialize AI and machine learning technologies.  Through
its subsidiaries and strategic alliances, Nexscient is building a diversified
portfolio of intelligent solutions across multiple industries, including
predictive maintenance, data annotation, and industrial automation.  For more
information, please visit https://nexscient.ai/ (https://nexscient.ai/) .

 

About Tekcapital plc

Tekcapital® creates value from investing in new, university-developed
discoveries that can enhance people's lives. Tekcapital is quoted on the AIM
market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in
the UK. For more information, please visit www.tekcapital.com
(http://www.tekcapital.com) .

LEI: 213800GOJTOV19FIFZ85

Forward-Looking Statements

This release contains statements that constitute forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of 1995 and
Section 27A of the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. These statements appear in a
number of places in this release and include all statements that are not
statements of historical fact regarding the intent, belief or current
expectations of Nexscient, Inc., its directors or its officers with respect
to, among other things: (i) financing plans; (ii) trends affecting its
financial condition or results of operations; (iii) growth strategy and
operating strategy; and (iv) performance of our products and services.  You
can identify these statements by the use of the words "may," "will," "could,"
"should," "would," "plans," "expects," "anticipates," "continue," "estimate,"
"project," "intend," "likely," "forecast," "probable," "potential," and
similar expressions and variations thereof are intended to identify
forward-looking statements.  Investors are cautioned that any such
forward-looking statements are not guarantees of future performance and
involve risks and uncertainties, many of which are beyond Nexscient's ability
to control, and actual results may differ materially from those projected in
the forward-looking statements as a result of various factors.  These risks
and uncertainties also include such additional risk factors as are discussed
in the Company's filings with the U.S. Securities and Exchange Commission,
including its Annual Report on Form 10-K for the fiscal year ended June 30,
2025, Forms 10-Q and 8-K, and in other filings we make with the Securities and
Exchange Commission from time to time.  These documents are available on the
SEC Filings section of the Investor Relations section of our website at
https://nexscient.ai (https://nexscient.ai) . The Company cautions readers not
to place undue reliance upon any such forward-looking statements, which speak
only as of the date made. The Company undertakes no obligation to update any
forward-looking statement to reflect events or circumstances after the date on
which such statement is made.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAUPGBWGUPAGWB



            Copyright 2019 Regulatory News Service, all rights reserved